Acanthamoeba keratitis is a corneal infection requiring prompt, targeted antimicrobial therapy. Selecting the correct regimen and applying it appropriately is critical to a successful outcome.
First-line management involves topical antifungal agents used in combination with specific antimicrobial agents, with therapy intensity and agent selection calibrated to clinical response and tolerability — the complete regimen, combinations, and decision algorithm are contained in the full protocol.